Table 1

Demographic and clinical characteristics

CharacteristicNo. (%) of patients*p value
Uniportal VATS
n = 65
Multiportal VATS
n = 63
Age, yr, mean ± SD67.6 ± 8.969.2 ± 7.90.28
Male sex32 (49)21 (33)0.08
BMI, mean ± SD29.0 ± 7.827.0 ± 4.50.10
FEV1, L, mean ± SD2.0 ± 0.62.0 ± 0.60.74
FEV1, % predicted, mean ± SD84.2 ± 21.987.3 ± 19.90.43
DLCO, % predicted, mean ± SD65.6 ± 20.065.8 ± 19.00.95
Current smoker13 (20.0)16 (25.4)0.77
Smoking history53 (81.5)48 (76.1)0.52
Average pack years, mean ± SD32.2 (±16.5)37.9 (17.0)0.10
Comorbidities
 Hypertension39 (60.0)40 (63.5)0.72
 COPD21 (32.3)10 (15.9)0.04
 Diabetes mellitus18 (27.7)11 (17.5)0.21
 Dyslipidemia14 (21.5)7 (11.1)0.15
 Hypercholesterolemia13 (20.0)6 (9.5)0.14
 Coronary artery disease11 (16.9)5 (7.9)0.18
 Previous stroke3 (4.6)5 (7.9)0.49
Histologic type0.27
 Adenocarcinoma48 (73.8)36 (57.1)
 Metastatic tumour5 (7.7)6 (9.5)
 Squamous cell carcinoma5 (7.7)8 (12.7)
 Neuroendocrine tumour3 (4.6)2 (3.2)
 Carcinoid tumour2 (3.1)3 (4.8)
 Other3 (4.6)5 (7.9)
Tumour size, cm, mean ± SD2.7 ± 1.52.8 ± 1.70.86
Tumour location0.11
 Left upper lobe13 (20.0)25 (39.7)
 Left lower lobe16 (24.6)7 (11.1)
 Right upper lobe14 (21.5)11 (17.5)
 Right middle lobe8 (12.3)6 (9.5)
 Right lower lobe14 (21.5)13 (20.6)
Cancer stage0.70
 01 (1.5)0
 IA21 (32.3)19 (30.2)
 IB25 (38.5)19 (30.2)
 IIA3 (4.6)4 (6.3)
 IIB3 (4.6)2 (3.2)
 IIIA7 (10.8)8 (12.7)
Operative procedure0.71
 Lobectomy43 (58.9)40 (57.1)
 Segmentectomy20 (27.4)17 (24.3)
 Wedge resection10 (13.7)13 (18.6)
  • BMI = body mass index; COPD = chronic obstructive pulmonary disease; DLCO = diffusing capacity of the lungs for carbon monoxide; FEV1 = forced expiratory volume in 1 second; SD = standard deviation; VATS = video-assisted thoracoscopic surgery.

  • * Unless indicated otherwise.